↓ Skip to main content

DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease

Overview of attention for article published in Clinical Epigenetics, March 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
2 news outlets
twitter
8 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease
Published in
Clinical Epigenetics, March 2021
DOI 10.1186/s13148-021-01051-3
Pubmed ID
Authors

Kimberly C. Paul, Steve Horvath, Irish Del Rosario, Jeff M. Bronstein, Beate Ritz

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 14%
Student > Ph. D. Student 5 14%
Student > Doctoral Student 3 9%
Unspecified 3 9%
Student > Master 3 9%
Other 6 17%
Unknown 10 29%
Readers by discipline Count As %
Neuroscience 5 14%
Biochemistry, Genetics and Molecular Biology 4 11%
Unspecified 3 9%
Medicine and Dentistry 3 9%
Agricultural and Biological Sciences 2 6%
Other 8 23%
Unknown 10 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2023.
All research outputs
#1,693,210
of 24,820,264 outputs
Outputs from Clinical Epigenetics
#94
of 1,412 outputs
Outputs of similar age
#44,344
of 430,632 outputs
Outputs of similar age from Clinical Epigenetics
#1
of 63 outputs
Altmetric has tracked 24,820,264 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,412 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,632 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.